FDA Gene Therapy Survey Seeks Info On Quality Controls & Monitoring
Executive Summary
FDA is gathering information on the state of the art in gene therapy research through a survey of clinical investigators.
You may also be interested in...
Gene Therapy Guidance Urges 15-Year Follow-Up, With Five "Close" Years
FDA's draft guidance on gene therapy studies follows the recommendations of the Biological Response Modifiers Advisory Committee in calling for 15 years of follow-up for patients
Gene Therapy Guidance Urges 15-Year Follow-Up, With Five "Close" Years
FDA's draft guidance on gene therapy studies follows the recommendations of the Biological Response Modifiers Advisory Committee in calling for 15 years of follow-up for patients
Gene Therapy Product QA Documentation May Become Key IND Element - FDA
Manufacturing quality assurance documentation could become a key component of gene therapy IND submissions, FDA Cellular & Gene Therapies Division Director Philip Noguchi, MD, suggested April 5.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: